Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKrm22 Plc Regulatory News (KRM)

Share Price Information for Krm22 Plc (KRM)

Share Price is delayed by 15 minutes
Get Live Data
34.00    0.00 (0.00%)
Bid:
33.00
Ask:
35.00
Spread: 2.00 (6.061%)
Market Cap: £20.17m
KRM Live PriceLast checked at - London Stock Exchange

Intraday Krm22 Plc Share Chart

Directorate Changes

30 Apr 2019 07:00

RNS Number : 4672X
KRM22 PLC
30 April 2019
 

 

KRM22 plc

 

("KRM22" or the "Company")

 

Directorate Changes

 

KRM22 plc, (AIM: KRM) the technology and software investment company that focuses on risk management for capital markets, announces the appointment of Garry Jones as an independent Non-Executive Director of the Company. Mr Jones will replace David Ellis, Independent Non-Executive Director, who notified the Board of his intention to step down from the Board with immediate effect after being with the Company since its IPO in early 2018. Mr Ellis is stepping down to focus on other business commitments and a relocation to the United States.

 

Garry has over 35 years' experience in financial services and has been CEO of three of the largest derivatives and OTC exchanges in Europe: BrokerTec, LIFFE and the London Metal Exchange ("LME"). He has contributed to the business change, growth, and globalisation in exchanges, driving the momentum behind electronic trading and increased efficiency in the post trade environment via straight-through clearing.

 

Garry was part of the initial management team at BrokerTec, becoming CEO and President of BrokerTec Europe, before running ICAP Electronic Broking (Europe) - the forerunner of NEX. Brokertec became the largest global OTC trading platform, with major strengths in government bonds and repo. He joined NYSE Euronext in 2005 and was Global Head of Derivatives (overseeing derivatives markets in Europe and the USA) and CEO of the NYSE LIFFE exchange. In 2013 he became Co-Head of Markets at HKEX and CEO of the LME, based in London but with an office in Hong Kong and spending considerable time in Asia, with a major focus on China. He left HKEX in 2017, remaining an advisor to the company until 2018.

 

Garry was a founder member of the Futures and Options Association's European Industry Council and was a member of the UK's Financial Services Authority senior Practitioner Panel that advised on new policy initiatives under the UK's former regulatory regime. He was on the Board of The Federation of European Security Exchanges and alternate Board member of the World Federation of Exchanges. He served as a Director of The London Clearing House as well as the Qatar Exchange.

 

With the resignation of David and the appointment of Garry, the Board remains comprised of three independent Non-Executive Directors and the three Executive Directors.

 

Keith Todd, Executive Chairman commented:

 

"All the team thank warmly David for his valuable contributions since KRM22's IPO and we wish him well with his new focus in the USA.

 

We are delighted to welcome Garry to the KRM22 Board. Garry brings deep knowledge and expertise of capital markets and has managed risks himself throughout his career in multiple ways. Garry's decision to join the KRM22 Board reflects his view of how important the KRM22 Global Risk Platform is and the opportunity we have to help customers reduce the cost and complexity of managing their risks. All the team welcome him warmly."

 

 

The following information is disclosed in relation to Garry Peter Jones, age 60, pursuant to Schedule Two paragraph (g) and Rule 17 of the AIM Rules for Companies:

 

Current Directorships / Partnerships:

 

Horatio Ventures

 

Previous Directorships / Partnerships (held in the past five years)

 

London Metal Exchange

LME Clear

HKEX Investment (UK)

LME Holding

 

 

Mr. Jones currently holds 176,471 ordinary shares in the Company, representing 0.97 per cent. of the issued share capital of the Company.

 

There is no further information to be disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies.

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

For further information please contact:

 

KRM22 plc

InvestorRelations@krm22.com

Keith Todd CBE, Executive Chairman and CEO

Karen Bach, COO

finnCap Ltd (Nominated Adviser and Sole Broker)

+44 (0)20 7220 0500

Carl Holmes / Kate Bannatyne - Corporate Finance

Alice Lane / Sunila de Silva - ECM

 

About KRM22 plc

KRM22 is a closed-ended investment company which listed on AIM on 30 April 2018. The Company has been established with the objective of creating value for its investors through the investment in, and subsequent growth and development of, target companies in the technology and software sector, with a focus on risk management in capital markets.

Through its investments and the Global Risk Platform, KRM22 helps capital market companies reduce the cost and complexity of risk management. The Global Risk Platform provides applications to help address firms' regulatory, market, technology and operations risk challenges and to manage their entire enterprise risk profile.

 

Capital markets companies' partner with KRM22 to optimize risk management systems and processes, improving profitability and expanding opportunities to increase portfolio returns by leveraging risk as alpha.

 

KRM22 PLC is listed on AIM and the Group is headquartered in London, with offices in several of the world's major financial centres.

 

See more about KRM22 at KRM22.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAPGUACCUPBGQB
Date   Source Headline
16th Sep 20207:00 amRNSInterim Results
17th Aug 20207:00 amRNSNew Customer Contract
23rd Jul 202010:49 amRNSIssue of Options
21st Jul 20207:00 amRNSTrading Update
3rd Jul 20201:37 pmRNSHolding(s) in Company
29th Jun 20207:00 amRNSConversion of Convertible Loan Note
25th Jun 202011:51 amRNSResult of AGM
2nd Jun 20207:00 amRNSNotice of AGM and Posting of Annual Report
27th May 20207:00 amRNSSubscription
21st May 20207:00 amRNSAUDITED RESULTS FOR THE YEAR ENDED 31 DEC 2019
20th May 20204:41 pmRNSHolding(s) in Company
19th May 20207:00 amRNSHolding(s) in Company
18th May 20208:53 amRNSHolding(s) in Company
14th May 20207:00 amRNSCompletion of Equity Fundraising
11th May 20207:00 amRNSUpdate on Equity Fundraising
7th May 20202:47 pmRNSStatement re. share price movement
17th Apr 20207:00 amRNSConsolidation of ownership of Irisium Ltd
2nd Apr 20207:00 amRNSDirectorate Changes
2nd Apr 20207:00 amRNSTrading Update
13th Jan 20204:30 pmRNSDirector/PDMR Shareholding
13th Jan 20207:00 amRNSTrading Update
3rd Dec 20197:00 amRNSDirectorate Changes
20th Nov 20198:03 amRNSKRM22 announces Market Risk solution for the GRP
14th Nov 20195:23 pmRNSHolding(s) in Company
7th Nov 20197:01 amRNSKRM22 announces partnership with deltaconX
7th Nov 20197:00 amRNSPlacing
31st Oct 20197:00 amRNSBusiness Update
3rd Oct 20197:00 amRNSNew customer contract
24th Sep 20194:40 pmRNSSecond Price Monitoring Extn
24th Sep 20194:35 pmRNSPrice Monitoring Extension
17th Sep 20197:00 amRNSInterim Results
11th Sep 20197:00 amRNSTrading Update and Notice of Interim Results
6th Aug 20197:00 amRNSKRM22 adds Digital Client Onboarding to offering
11th Jul 20197:00 amRNSPartnership with Quant Foundry
11th Jul 20197:00 amRNSHalf Year Trading Update
28th Jun 201911:52 amRNSResult of AGM
25th Jun 201910:17 amRNSHolding(s) in Company
19th Jun 20197:00 amRNSPartnership with Neotas
6th Jun 20199:00 amRNSNotice of AGM & Posting of Annual Report
6th Jun 20197:00 amRNSSubscription
5th Jun 20196:13 pmRNSHolding(s) in Company
3rd Jun 20197:01 amRNSDirector role change
3rd Jun 20197:00 amRNSFinal Results
3rd Jun 20197:00 amRNSCompletion of Acquisition
31st May 20197:00 amRNSKRM22 announces partnership with Trailight Ltd
30th May 20197:00 amRNSAcquisition of Object+
1st May 20197:00 amRNSUpdate on Fundraising
30th Apr 20197:00 amRNSDirectorate Changes
29th Apr 20197:00 amRNSDebt Facility Secured
16th Apr 20195:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.